Learn languages naturally with fresh, real content!

tap to translate recording

Explore By Region

flag Applied DNA Sciences shifts focus to genetic medicines, selling assets and cutting costs.

flag Applied DNA Sciences has announced a strategic shift to focus on producing essential materials for genetic medicines. flag The company plans to sell its CertainT platform, reduce operating expenses by 15%, and keep Applied DNA Clinical Labs for its profitable pharmacogenomic testing services. flag The completion of its GMP manufacturing facility is expected by January 9, 2025, with potential annual revenue of $4 million to $16 million.

5 Articles